Krabbe Disease Global Patient Registry
Launched by STATE UNIVERSITY OF NEW YORK AT BUFFALO · Dec 13, 2016
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
The Krabbe Disease Global Patient Registry is a clinical trial aimed at gathering information about individuals diagnosed with Krabbe disease, a rare genetic condition that affects the nervous system. The study seeks to understand which symptoms appear first, how certain genetic factors and enzyme levels might influence the disease's progression, and which tests can help predict how severe the disease might become. By collecting this information, researchers hope to improve future diagnosis and treatment options for those affected.
Anyone diagnosed with Krabbe disease, those who are at risk for the disease, and family members of affected individuals can participate in this study. If you join, you’ll be asked to provide information about your experience with the disease, which will help researchers better understand it. The study is currently looking for participants of all ages and genders. This is a great opportunity to contribute to important research that could help improve the lives of people living with Krabbe disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Anyone diagnosed with Krabbe disease
- • Anyone at-risk for Krabbe disease
- • Family members of someone diagnosed with, or at-risk for, Krabbe disease.
- Exclusion Criteria:
- • Anyone who is not diagnosed with, or at-risk for, Krabbe disease
- • Anyone who is not a family member of someone diagnosed with, or at-risk for, Krabbe disease
About State University Of New York At Buffalo
The State University of New York at Buffalo (SUNY Buffalo) is a prominent research institution dedicated to advancing healthcare through innovative clinical trials and studies. Renowned for its commitment to academic excellence and interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore novel therapeutic approaches and enhance patient outcomes. SUNY Buffalo's clinical trials encompass a wide range of medical disciplines, driven by a mission to translate research discoveries into practical applications that benefit diverse populations. With a focus on ethical standards and rigorous methodologies, the university fosters an environment that supports cutting-edge research while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Buffalo, New York, United States
Patients applied
Trial Officials
Thomas J. Langan, MD
Principal Investigator
Clinical Director, Clinical Research, Institute for Myelin and Glial Exploration
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials